Kadaba; Pankaja K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kadaba; Pankaja K..The latest application filed is for "delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke".

Company Profile

0.4.3

Kadaba; Pankaja K. - Chadds Ford PA
Kadaba; Pankaja K. - Lexington KY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke App 20060058357 - Kadaba; Pankaja K.	2006-03-16
Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke App 20040073039 - Kadaba, Pankaja K.	2004-04-15
.delta.2-1,2,3-triazoline Anticonvulsants And Their Active Metabolite Analogues, The Aminoalkylpyridines, Are Excitatory Amino Acid Antagonists And Antiischemic Agents, Useful In The Treatment Of Cerebral Ischemia Resulting From Stroke Grant 6,638,954 - Kadaba October 28, 2	2003-10-28
Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke App 20020111371 - Kadaba, Pankaja K.	2002-08-15
Hydrazones, hydrazines, semicarbazones and thiosemicarbazones derived from pyridyl ketones as anticonvulsant drugs and excitatory amino acid antagonists Grant 5,942,527 - Kadaba , et al. August 24, 1	1999-08-24
Aminoalkylpyridine compounds which are useful as anitconvulsant drugs, excitatory amino acid inhibitors and NMDA sigma receptor antagonists Grant 5,648,369 - Kadaba July 15, 1	1997-07-15
Triazoline anticonvulsant drugs Grant 4,511,572 - Kadaba April 16, 1	1985-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.